Trade

with

Uroplasty Inc
(NASDAQ: UPI)
AdChoices
2.43
-0.06
-2.41%
After Hours :
-
-
-

Open

2.44

Previous Close

2.49

Volume (Avg)

27.50k (33.55k)

Day's Range

2.42-2.44

52Wk Range

2.19-5.40

Market Cap.

54.89M

Dividend Rate ( Yield )

-

Beta

-1.66

Shares Outstanding

22.05M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 24.58M

    • Net Income

    • -5.35M

    • Market Cap.

    • 54.89M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -23.62

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -1.66

    • Forward P/E

    • -8.30

    • Price/Sales

    • 2.12

    • Price/Book Value

    • 4.82

    • Price/Cash flow

    • -13.87

      • EBITDA

      • -4.93M

      • Return on Capital %

      • -34.11

      • Return on Equity %

      • -44.80

      • Return on Assets %

      • -34.11

      • Book Value/Share

      • 0.52

      • Shares Outstanding

      • 22.05M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 5.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.31

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 9.30

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 10.76

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 87.69

            • 64.08

            • Pre-Tax Margin

            • -23.31

            • 15.19

            • Net Profit Margin

            • -23.62

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 84.90

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -23.30

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -23.60

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.34

              • Current Ratio

              • 4.11

              • 2.55

              • Quick Ratio

              • 3.78

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 1.37

              • 1.86

              • Book Value/Share

              • 0.52

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -8.70

                • 34.48

                • P/E Ratio 5-Year High

                • -32.76

                • 224.03

                • P/E Ratio 5-Year Low

                • -3.63

                • 60.23

                • Price/Sales Ratio

                • 2.06

                • 3.20

                • Price/Book Value

                • 4.69

                • 3.23

                • Price/Cash Flow Ratio

                • -13.87

                • 18.66

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -44.80

                        (-26.70)

                      • 12.33

                        (18.16)

                      • Return on Assets %

                        (5-Year Average)

                      • -34.11

                        (-22.30)

                      • 6.62

                        (8.69)

                      • Return on Capital %

                        (5-Year Average)

                      • -44.80

                        (-26.70)

                      • 8.49

                        (11.48)

                      • Income/Employee

                      • -

                      • 34.11k

                      • Inventory Turnover

                      • -

                      • 2.77

                      • Asset Turnover

                      • 1.44

                      • 0.51

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -5.30M
                      Operating Margin
                      -21.56
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -13.87
                      Ownership

                      Institutional Ownership

                      54.53%

                      Top 10 Institutions

                      46.78%

                      Mutual Fund Ownership

                      14.26%

                      Float

                      85.00%

                      5% / Insider Ownership

                      10.59%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • MFS® New Discovery Fund

                      •  

                        1,452,126

                      • 0.00

                      • 6.59

                      • MFS® VIT New Discovery Series

                      •  

                        622,565

                      • 19.35

                      • 2.82

                      • Vanguard Total Stock Mkt Idx

                      •  

                        292,998

                      • 0.00

                      • 1.33

                      • Vanguard Extended Market Index Fund

                      •  

                        198,871

                      • 0.00

                      • 0.90

                      • Strategic Advisers® Small-Mid Cap Fund

                      •  

                        191,757

                      • 12.38

                      • 0.87

                      • Perkins Discovery Fund

                      •  

                        100,000

                      • 0.00

                      • 0.45

                      • Cortina Small Cap Growth Fund

                      •  

                        68,951

                      • 10.05

                      • 0.31

                      • Fidelity Spartan® Extended Mkt Indx Fd

                      •  

                        64,999

                      • 0.00

                      • 0.29

                      • iShares Micro-Cap

                      •  

                        62,370

                      • 0.00

                      • 0.27

                      • DFA U.S. Small Cap Portfolio

                      •  

                        12,442

                      • 0.00

                      • 0.06

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • MFS Investment Management K.K.

                      •  

                        2,557,142

                      • -1.58%

                      • 11.60

                      • Cortina Asset Management LLC

                      •  

                        1,763,618

                      • -2.35%

                      • 8.00

                      • Orbimed Advisors, LLC

                      •  

                        1,363,500

                      • 0.00%

                      • 6.18

                      • Perkins Capital Management Inc

                      •  

                        1,310,011

                      • +1.11%

                      • 5.94

                      • Manatuck Hill Partners LLC

                      •  

                        709,336

                      • 0.00%

                      • 3.22

                      • Perceptive Advisors LLC

                      •  

                        668,287

                      • +29.07%

                      • 3.03

                      • Rothschild Capital Management, LLC

                      •  

                        579,112

                      • +45.76%

                      • 2.63

                      • Vanguard Group, Inc.

                      •  

                        472,371

                      • 0.00%

                      • 2.14

                      • Dafna Capital Management LLC

                      •  

                        441,859

                      • +52.72%

                      • 2.00

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Devices

                      Type

                      Speculative Growth

                      Style

                      Small Growth

                      Uroplasty Inc was incorporated on January 21, 1992 as a Minnesota corporation. It is a medical device company. It develops, manufactures and markets innovative, proprietary products for the treatment of voiding dysfunctions. Its prim...moreary focus is on two products: the Urgent PC® Neuromodulation System, and Macroplastique® Implants. The Urgent PC® Neuromodulation System delivers percutaneous tibial nerve stimulation for office-based treatment of overactive bladder and the associated symptoms of urinary urgency, urinary frequency, and urge incontinence. The Macroplastique® Implants is an injectable, urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. The Company is focusing its sales and marketing efforts primarily on urol...moreogists, urogynecologists and gynecologists with significant office-based and outpatient surgery-based patient volume. The testing, manufacturing, promotion, marketing and distribution of the Company’s products in the United States, Europe and other parts of the world are subject to regulation by numerous governmental authorities, including the FDA, the European Union and other analogous agencies.lessless

                      Key People

                      Mr. Robert E. Kill

                      CEO/Director/President/Chairman of the Board

                      Mr. Brett A. Reynolds

                      CFO/Senior VP/Secretary

                      Mr. Marc M. Herregraven

                      Vice President, Divisional

                      Daniel Merz

                      Vice President, Divisional

                      David Perry

                      Vice President, Divisional

                      • Uroplasty Inc

                      • 5420 Feltl Road

                      • Minnetonka, MN 55343

                      • USA.Map

                      • Phone: +1 952 426-6140

                      • Fax: +1 952 426-6199

                      • uroplasty.com

                      Incorporated

                      1992

                      Employees

                      118

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: